by GlobeNewsWire | Aug 8, 2016 | Canadian Stocks, Globe Newswire
Patent Covers Lipid Particle Compositions Known to be Effective for Delivery of Nucleic Acids Including mRNA VANCOUVER, B.C. and DOYLESTOWN, Pa., Aug. 08, 2016 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading hepatitis B virus...
by GlobeNewsWire | Aug 8, 2016 | Globe Newswire
EXTON, Pa., Aug. 08, 2016 (GLOBE NEWSWIRE) — Fibrocell Science, Inc. (NASDAQ:FCSC) (Fibrocell) today announced that it intends to offer and sell shares of its common stock and related warrants to purchase shares of its common stock in an underwritten public...
by GlobeNewsWire | Aug 8, 2016 | Globe Newswire
SAN RAFAEL, Calif., Aug. 08, 2016 (GLOBE NEWSWIRE) — BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) announced today an offering, subject to market and other conditions, of 7,500,000 shares of its common stock in an underwritten public offering. BioMarin has also...
by GlobeNewsWire | Aug 4, 2016 | Globe Newswire
– Second Quarter 2016 Total BioMarin Revenue Increases 20.0% Y/Y to $300.1 million- Vimizim Net Product Revenue Increases 98.1% Y/Y and Contributes $106.8 million in the Second Quarter 2016; Vimizim Full-year Revenue Guidance Increased to $340 to $360 million-...
by GlobeNewsWire | Aug 4, 2016 | Globe Newswire
CAMBRIDGE, Mass., Aug. 04, 2016 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe diseases of the central nervous system (CNS), today announced its second quarter...